UBS Group
NKTX icon

UBS Group’s Nkarta NKTX Stock Holding History

UBS Group’s Portfolio NKTX Stock Details NKTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$100K Sell
47,497
-32,365
-41% -$72.4K ﹤0.01% 7001
2025
Q4 		$148K Buy
79,862
+59,187
+286% +$118K ﹤0.01% 6725
2025
Q3 		$42.8K Sell
20,675
-194,830
-90% -$400K ﹤0.01% 7676
2025
Q2 		$358K Sell
215,505
-24,951
-10% -$45.7K ﹤0.01% 6291
2025
Q1 		$442K Sell
240,456
-41,212
-15% -$84.5K ﹤0.01% 5949
2024
Q4 		$701K Buy
281,668
+188,302
+202% +$581K ﹤0.01% 5607
2024
Q3 		$422K Buy
93,366
+20,463
+28% +$116K ﹤0.01% 5347
2024
Q2 		$431K Buy
72,903
+41,388
+131% +$293K ﹤0.01% 5117
2024
Q1 		$341K Sell
31,515
-2,769
-8% -$28.8K ﹤0.01% 5480
2023
Q4 		$226K Buy
34,284
+19,978
+140% +$51.8K ﹤0.01% 5709
2023
Q3 		$19.9K Sell
14,306
-4,336
-23% -$8.23K ﹤0.01% 6809
2023
Q2 		$40.8K Sell
18,642
-7,937
-30% -$34.9K ﹤0.01% 6581
2023
Q1 		$94.4K Sell
26,579
-236
-0.9% -$1.12K ﹤0.01% 5949
2022
Q4 		$161K Sell
26,815
-2,197
-8% -$22.2K ﹤0.01% 5655
2022
Q3 		$381K Sell
29,012
-20,123
-41% -$288K ﹤0.01% 4574
2022
Q2 		$605K Buy
49,135
+47,439
+2,797% +$623K ﹤0.01% 4115
2022
Q1 		$19K Sell
1,696
-4,253
-71% -$45.5K ﹤0.01% 7516
2021
Q4 		$92K Sell
5,949
-45,936
-89% -$788K ﹤0.01% 6386
2021
Q3 		$1.44M Buy
51,885
+43,203
+498% +$1.37M ﹤0.01% 3866
2021
Q2 		$275K Sell
8,682
-19,499
-69% -$562K ﹤0.01% 5139
2021
Q1 		$927K Buy
28,181
+28,146
+80,417% +$1.34M ﹤0.01% 4339
2020
Q4 		$2K Sell
35
-1,052
-97% -$43.7K ﹤0.01% 8108
2020
Q3 		$33K Buy
+1,087
New +$32K ﹤0.01% 5932

Other funds holding NKTX

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $915M AUM 209.71% 1-Year Est. Return
GP
GSK plc London $599M AUM
MAM
Monaco Asset Management Monaco $542M AUM 54.4% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

UBS Group's NKTX Position: Q1 2026 in Review

UBS Group reduced its Nkarta (NKTX) stake by 41% in Q1 2026, selling an estimated $72.4K and leaving 47,497 shares worth $100K. The position accounts for ﹤0.01% of the portfolio, ranked #7001.

UBS Group first reported a position in NKTX in Q3 2020 and has held it in 23 quarters since. The position peaked at $1.44M in Q3 2021. 126 funds tracked by Wall St. Rank hold NKTX as of Q1 2026.

  • UBS Group held 47,497 shares of Nkarta worth $100K as of Q1 2026.
  • UBS Group sold 32,365 Nkarta shares in Q1 2026, an estimated $72.4K.
  • Nkarta made up ﹤0.01% of UBS Group's portfolio in Q1 2026, its #7001 holding.
  • UBS Group first reported a position in Nkarta in Q3 2020 and has held it in 23 quarters since.
  • UBS Group's Nkarta position peaked at $1.44M in Q3 2021.
  • 126 funds tracked by Wall St. Rank held Nkarta as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.